Clinical Research
o extend the benefits of genomic testing research for reproductive health labs, Thermo Fisher Scientific today launched two new next-generation sequencing-...
July 18, 2023 | News
- ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop...
July 18, 2023 | News
The new HP injectable manufacturing line meets Occupational Exposure Limits (OEL) as low as 10 ng/m3 and utilizes fully enclosed isolation systems and...
July 18, 2023 | News
Lonza’s new cell culture media system is designed to optimize the production of therapeutic monoclonal antibodies The two-part production system i...
July 17, 2023 | News
According to the agreement, GeneQuantum will provide InxMed with its independently developed, globally leading technologies in site-specific glycan conjuga...
July 17, 2023 | News
Two new CRISPR-based strategies offer hope for next-generation Alzheimer's treatments. One seeks to dampen the impact of the most common Alzheimer's ris...
July 17, 2023 | News
OneStudyTeam, the maker of the patient enrollment management platform StudyTeam, today announced that StudyTeam is now being used by more than 4,000 clinic...
July 17, 2023 | News
"We are delighted to be entering this early-stage R&D collaboration with argenx. argenx is one of the industry's most exciting companies, and their bel...
July 13, 2023 | News
In recent years, the growing awareness among consumers regarding environmental protection and health has driven the demand for vegan collagen. This growing...
July 12, 2023 | News
With the inauguration of a new state-of-the-art cell therapy lab in early 2022, BeiGene is looking to broaden collaboration and expand ...
July 12, 2023 | News
The multi-center clinical randomized controlled trial on the ''treatment of Chronic Obstructive Pulmonary Disease (''COPD'') by targeted lung denervation a...
July 11, 2023 | News
RemeGen Co., Ltd. ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a fully-integrated commercial-stage biotechnology company, announce...
July 10, 2023 | News
80Bio, Inc. a clinical stage biotechnology company focused on the development of precision oncology medicines, today announced that the U.S. Food and Drug ...
July 10, 2023 | News
Since April of last year, GeneQuantum and Aimed Bio have been collaborating on the joint development of a FGFR3-targeting ADC named GQ1011/AMB302. The prog...
July 07, 2023 | News
Most Read
Bio Jobs
News
Editor Picks